Four-Year Outcomes from a Randomized Clinical Trial of Docosahexaenoic Acid (DHA) Supplementation in X-Linked Retinitis Pigmentosa (XLRP)
Year: 2003
Type: article
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1138389725
